Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001096906-11-000623
Filing Date
2011-03-31
Accepted
2011-03-31 15:23:30
Documents
13
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 amexdrug10k.txt 10-K 170193
2 amexdrug10k20101231ex10-09.htm EX-10.9 661764
3 amexdrug10k20101231ex10-10.htm EX-10.10 14118
4 amexdrug10k20101231ex10-11.htm EX-10.11 413539
5 amexdrug10k20101231ex10-12.htm EX-10.12 22257
6 amexdrug10kexh311.txt EX-31.1 4216
7 amexdrug10kexh312.txt EX-31.2 4217
8 amexdrug10kexh321.txt EX-32.1 1379
9 amexdrug10kexh322.txt EX-32.2 1391
10 amexdrug10k20101231ex10-0921.jpg GRAPHIC 2771
11 a1.jpg GRAPHIC 61175
12 a2.jpg GRAPHIC 4183
13 a3.jpg GRAPHIC 85194
  Complete submission text file 0001096906-11-000623.txt   1505815
Mailing Address 369 SOUTH DOHENY DR SUITE 326 BEVERLY HILLS CA 90211
Business Address 369 SOUTH DOHENY DR SUITE 326 BEVERLY HILLS CA 90211 3108550475
AMEXDRUG CORP (Filer) CIK: 0000045621 (see all company filings)

EIN.: 952251025 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-10304 | Film No.: 11725821
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries